Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
Filing tables
Filing exhibits
- 10-K Annual report
- 2.1 Agreement and Plan of Reorganization, Dated As of September 10, 2021, by and Among Inmed Pharmaceuticals Inc., Inmed LLC, Baymedica, Inc., BM Rep, LLC, As the Stockholder Representative, and Certain Stockholders Thereto
- 4.6 Form of Series a Warrant (to Be Issued Pursuant to the Agreement and Plan of Reorganization, Dated As of September 10, 2021, by and Among Inmed Pharmaceuticals Inc., Inmed LLC, Baymedica, Inc., BM Rep, LLC
- 4.7 Form of Series B Warrant (to Be Issued Pursuant to the Agreement and Plan of Reorganization, Dated As of September 10, 2021, by and Among Inmed Pharmaceuticals Inc., Inmed LLC, Baymedica, Inc., BM Rep, LLC,
- 10.10 Form of Inmed Pharmaceuticals Inc. Indemnification Agreement Entered into with Each Member of the Board of Directors and Chief Financial Officer
- 21.1 Subsidiaries of Inmed Pharmaceuticals Inc
- 23.1 Consent of KPMG LLP, Independent Registered Public Accounting Firm
- 31.1 Certification
- 31.2 Certification
- 32.1 Certification
- 32.2 Certification
- Download Excel data file
- View Excel data file
Associated INM transcripts
INM similar filings
Filing view
External links
Exhibit 32.1
Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Eric A. Adams, the President and Chief Executive Officer of InMed Pharmaceuticals Inc. (the “Company”), hereby certify that, to my knowledge:
1. The Annual Report on Form 10-K for the year ended June 30, 2021 (the “Report”) of the Company fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: September 24, 2021
/s/ Eric A. Adams | |
Name: Eric A. Adams | |
Title: President and Chief Executive Officer |